Prevalence of Hidradenitis Suppurativa in Brussels, Belgium: Validation of a Screening Questionnaire.

IF 2.7 3区医学 Q2 DERMATOLOGY

Dermatology Pub Date : 2025-07-07 DOI:10.1159/000539477

Fadwa El Aissoug, Wassila Bouazza, Hassane Njimi, Joelle Feghali, Véronique Del Marmol, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Farida Benhadou

{"title":"Prevalence of Hidradenitis Suppurativa in Brussels, Belgium: Validation of a Screening Questionnaire.","authors":"Fadwa El Aissoug, Wassila Bouazza, Hassane Njimi, Joelle Feghali, Véronique Del Marmol, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Farida Benhadou","doi":"10.1159/000539477","DOIUrl":null,"url":null,"abstract":"Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent and debilitating skin disease, with a poorly understood global burden. The prevalence of HS in Belgium is not yet known. We aimed to determine the prevalence of the disease in the Belgian context and validate a screening questionnaire.Materials and methods: Conducted as part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative, this monocenter cross-sectional study involved 500 healthy adults accompanying patients at the Erasme Hospital in Brussels. Participants gave their consent and completed a screening questionnaire. All screen-positive and a subset of some screen-negative participants underwent clinical examination by a dermatologist. The severity of the disease was assessed using the Hurley staging.Results: The prevalence of HS in the sample was 1.6% (8/500; 95% Cl: 0.81%-3.13%). There were no statistically significant demographic differences between the group control and the HS group. The screening questionnaire demonstrated a sensitivity of 100%, a specificity of 89%, a positive predictive value of 56% and a negative predictive value of 100%. Most of the patients diagnosed with HS were Hurley I (6/8) and the axilla was the most affected area.Conclusion: The study uncovered a 1.6% prevalence of HS among a cohort of 500 Belgian participants and contributed to the GHiSA project. The high sensitivity and specificity of the screening questionnaire suggests it is an effective tool for detecting HS in the general population.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233962/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000539477","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent and debilitating skin disease, with a poorly understood global burden. The prevalence of HS in Belgium is not yet known. We aimed to determine the prevalence of the disease in the Belgian context and validate a screening questionnaire.

Materials and methods: Conducted as part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative, this monocenter cross-sectional study involved 500 healthy adults accompanying patients at the Erasme Hospital in Brussels. Participants gave their consent and completed a screening questionnaire. All screen-positive and a subset of some screen-negative participants underwent clinical examination by a dermatologist. The severity of the disease was assessed using the Hurley staging.

Results: The prevalence of HS in the sample was 1.6% (8/500; 95% Cl: 0.81%-3.13%). There were no statistically significant demographic differences between the group control and the HS group. The screening questionnaire demonstrated a sensitivity of 100%, a specificity of 89%, a positive predictive value of 56% and a negative predictive value of 100%. Most of the patients diagnosed with HS were Hurley I (6/8) and the axilla was the most affected area.

Conclusion: The study uncovered a 1.6% prevalence of HS among a cohort of 500 Belgian participants and contributed to the GHiSA project. The high sensitivity and specificity of the screening questionnaire suggests it is an effective tool for detecting HS in the general population.

查看原文本刊更多论文

比利时布鲁塞尔化脓性汗腺炎的流行：筛选问卷的验证。

背景：化脓性汗腺炎（HS）是一种慢性、炎症性、复发性和衰弱性皮肤病，对全球负担知之甚少。HS在比利时的流行情况尚不清楚。我们的目的是确定该疾病在比利时的流行情况，并验证筛查问卷。材料和方法：作为全球化脓性汗腺炎地图集（GHiSA）计划的一部分，这项单中心横断面研究涉及500名在布鲁塞尔Erasme医院陪伴患者的健康成年人。参与者表示同意并完成了一份筛选问卷。所有筛检阳性和部分筛检阴性的参与者接受了皮肤科医生的临床检查。采用Hurley分期评估疾病的严重程度。结果：样本中HS患病率为1.6% (8/500；95% Cl: 0.81% ~ 3.13%)。对照组与HS组在人口统计学上无显著差异。筛查问卷的敏感性为100%，特异性为89%，阳性预测值为56%，阴性预测值为100%。HS患者以Hurley I型（6/8）居多，以腋窝为重灾区。结论：该研究在500名比利时参与者中发现了1.6%的HS患病率，并为GHiSA项目做出了贡献。筛查问卷的高灵敏度和特异性表明它是检测普通人群HS的有效工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Dermatology 医学-皮肤病学

CiteScore

6.40

自引率

2.90%

发文量

审稿时长

1 months

期刊介绍： Published since 1893, ''Dermatology'' provides a worldwide survey of clinical and investigative dermatology. Original papers report clinical and laboratory findings. In order to inform readers of the implications of recent research, editorials and reviews prepared by invited, internationally recognized scientists are regularly featured. In addition to original papers, the journal publishes rapid communications, short communications, and letters to ''Dermatology''. ''Dermatology'' answers the complete information needs of practitioners concerned with progress in research related to skin, clinical dermatology and therapy. The journal enjoys a high scientific reputation with a continually increasing impact factor and an equally high circulation.